Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Early syndecan-4 upregulation predicts cognitive and pathological trajectories in Alzheimer disease.

Alzheimer's research & therapy·2026
Same author

Usage and positivity rates of Alzheimer's disease biomarkers in a memory clinic.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

<i>Trans</i>-eQTLs reveal the architecture of human gene regulatory networks.

medRxiv : the preprint server for health sciences·2026
Same author

Low overlap of plasma and CSF protein quantitative trait loci affects protein discovery for neurological disease.

Science translational medicine·2026
Same author

GPND-AI NULISA: A 15-Protein AI classifier for diagnosis and co-pathology profiling across neurodegenerative diseases.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

[11C]CS1P1 PET links T-cell-associated immune activation with endothelial and astrocytic responses.

Research square·2026
Same journal

Multimorbidity burden and patterns associated with DeepBrainNet-derived brain-age gap in dementia-free older adults: A community-based study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Reply to "Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities".

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Correlates and predictors of self-efficacy among dementia caregivers: D-CARE findings.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

What should convince a clinician of disease modification in Alzheimer's disease clinical trials?

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Primary cilia-extracellular vesicle crosstalk in Alzheimer's disease: Emerging mechanisms and biomarker potential.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
查看所有相关文章

相关实验视频

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

生物标志物 生物标志物

Katherine Gong1,2, Jigyasha Timsina1,2, Muhammad Ali1,2

  • 1Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 24, 2025
PubMed
概括
此摘要是机器生成的。

这项研究确定了78种与阿尔茨海默病 (AD) 相关的血蛋白,并验证了血pTau217作为生物标志物. 核酸链接免疫三明治测试 (NULISA) 平台在诊断神经退行性疾病方面显示出前景.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

相关实验视频

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

科学领域:

  • 神经科学是一个神经科学.
  • 生物化学 生物化学
  • 生物标志物发现发现

背景情况:

  • 血分析为神经退行性疾病提供最少侵入性的生物标志物.
  • 核酸链接免疫三明治测试 (NULISA) 平台被用于量化123个血蛋白.
  • 这项研究包括3000多名患有阿尔茨海默氏症 (AD),勒维体痴呆症 (DLB),前性痴呆症 (FTD),帕金森病 (PD) 和对照患者.

研究的目的:

  • 为了确定神经退行症的一般和疾病特异性血蛋白生物标志物.
  • 评估NULISA平台在量化这些生物标志物的表现.
  • 为了将血蛋白水平与已确定的神经成像和液体生物标志物相关联.

主要方法:

  • 使用NULISA对3668个样本中的123个血蛋白质进行量化.
  • 对AD,DLB,FTD和PD进行了差异丰度,ROC和AUC分析.
  • 分析包括与粉样蛋白PET,蛋白PET,CSF Aβ42 / Aβ40和CDR得分的相关性.

主要成果:

  • 78种与AD相关的蛋白质,2种与DLB相关的蛋白质,2种与FTD相关的蛋白质,1种与PD相关的蛋白质.
  • 血pTau217的准确性很高 (AD的AUC为0.81,粉样蛋白阳性为0.95).
  • 血pTau217和百叶状体水平之间达到了很高的一致性 (93.59%).

结论:

  • 在神经退行性疾病中,NULISA是量化血蛋白质的可靠平台.
  • 血pTau217是一种经过验证的AD预测生物标志物,与神经成像标志物有很强的相关性.
  • 这些发现支持NULISA在神经退行性疾病诊断中的研究和临床应用的潜力.